This is an excerpt from a paper by Adam Falconi, the recipient of the 2015 Barry D. Tomo Memorial Prize for best research paper on a subject related to industrial…
Tag: Adam Falconi
IP Intensive Program: A Semester at Teva Canada - An Insider's Look at the Pharmaceutical Industry
This past fall I had the privilege of participating in Osgoode Hall Law School’s Intellectual Property and Technology Law Intensive Program. The placement allowed me to spend my fall semester…
Certainly Commendable but Perhaps not Practical – Canada’s Competition Bureau Releases Guidelines on Pharmaceutical Patent Litigation Settlements
On September 23, Canada’s Competition Bureau (“the Bureau”) announced landmark guidelines regarding the consideration of pharmaceutical patent litigation settlements under Canada’s competition law framework. The Bureau’s guidelines on this issue…
Getting Profits From Patents: An Interview with Ed Fan and Loreto Grimaldi
The course Legal Values: Commercializing Intellectual Property is being offered for the first time at Osgoode Hall Law School this winter term. The IPilogue sat down with Adjunct Professors, Ed Fan (Torys LLP,…
CETA: A Very Reasonable Canadian-esque Compromise on Pharmaceutical Intellectual Property Law Changes
At long last, the Canadian Federal Government and the European Commission announced in October that a political agreement has been reached regarding the much anticipated Comprehensive Economic and Trade Agreement…
SickKids in Court - Are Public-Private Research Collaborations a Hindrance or a Driver of the Innovative Process?
A recent lawsuit filed by Myriad Genetics involving the alleged infringement of their controversial breast cancer screening tool has included the prestigious Toronto SickKids hospital as a co-plaintiff. This lawsuit…